Internal Medicine, Hematology & Oncology · Woodbury, NY
NPI
1508857772
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
40 Crossways Park Drive
Woodbury, NY, 11797
Phone (516) 921-5533
Groups this clinician bills Medicare through
Medicare paid, 2024
$719K
79,477 services
Medicare patients, 2024
914
Average age 78
Drug cost, 2024
$2.9M
583 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nancy N Sun was code Q0138 (injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)), 31,620 times for 32 patients. In total Nancy N Sun billed 79,477 services in 76 codes, and Medicare paid $719K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-10-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 31,620 | 32 | $0.28 | $8,741 |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 7,040 | 18 | $6.41 | $45K |
| 36415 Venipuncture Blood Collection | Office | 1,669 | 590 | $8.64 | $14K |
| 85025 Blood Count | Office | 1,640 | 588 | $7.59 | $12K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 900 | 473 | $14.23 | $13K |
| 99213 Office E&M - Established | Office | 852 | 425 | $75.22 | $64K |
| 99214 Office E&M - Established | Office | 542 | 272 | $108.99 | $59K |
| 99232 Hospital E&M - Subsequent | Facility | 470 | 249 | $68.39 | $32K |
| 96372 Injection Administration | Office | 228 | 36 | $12.28 | $2,800 |
| 99222 Hospital E&M - Initial | Facility | 137 | 128 | $113.47 | $16K |
| 99215 Office E&M - Established | Office | 122 | 84 | $158.37 | $19K |
| 96375 Injection Administration | Office | 106 | 17 | $13.78 | $1,460 |
| 99204 Office E&M - New | Office | 61 | 61 | $138.52 | $8,450 |
| 96413 Chemotherapy Administration | Office | 61 | 20 | $117.34 | $7,158 |
| 96374 Injection Administration | Office | 57 | 31 | $34.10 | $1,944 |
By year: 2022 $1.5M for 110,923 services; 2023 $998K for 80,986 services; 2024 $719K for 79,477 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,669 | 590 | $8.64 | $14K |
| 85025 Blood Count | 1,640 | 588 | $7.59 | $12K |
Medicare prescription drug claims, 2024
In 2024, the drug Nancy N Sun prescribed most often to Medicare patients was Anastrozole, with 133 prescriptions and refills. In total Nancy N Sun wrote 583 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 133 | 385 | 42 | $2,539 |
| Hydroxyurea Generic | 57 | 165 | 21 | $2,657 |
| Xarelto Rivaroxaban | 55 | 157 | 18 | $87K |
| Eliquis Apixaban | 40 | 83 | 13 | $47K |
| Calquence Acalabrutinib Maleate | 40 | 46 | Under 11 | $671K |
| Imbruvica Ibrutinib | 28 | 28 | Under 11 | $450K |
| Letrozole Generic | 26 | 78 | Under 11 | $627 |
| Jakafi Ruxolitinib Phosphate | 25 | 25 | Under 11 | $1.1M |
| Exemestane Generic | 24 | 50 | Under 11 | $2,006 |
| Raloxifene Hcl Generic | 22 | 66 | Under 11 | $954 |
| Imatinib Mesylate Generic | 19 | 41 | Under 11 | $242K |
| Ondansetron Odt Ondansetron | 18 | 18 | 12 | $270 |
| Prednisone Generic | 17 | 25 | Under 11 | $121 |
| Prochlorperazine Maleate Generic | 16 | 16 | 13 | $411 |
Brand drugs: 204 claims; generic drugs: 379 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Nancy N Sun were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.